CEBPA and acute myeloid leukemia: Several factors affecting AML prognosis have been identified, including somatic mutations in genes such as NPM1, FLT3-ITD, CEBPA, WT1, ASXL1, IDH1/2, DNMT3A, and RUNX1 [6–10].